Tetrahydro-4
H
-chromene-3-carbonitrile derivatives
4a-c
where prepared from the reaction of 1,4-cyclohexane dione
(1)
, malononitrile
(2)
and either of benzaldehyde
(3a)
, 2-chlorobenzaldehyde
(3b)
or 4-methoxybenzaldehyde
(3c)
in ethanol containing triethylamine. Compound
4b
was used to prepare pyrazole, pyrimidine and thiazole derivatives. Moreover, tetrahydrobenzo[
d
]thiazole derivative
18
was prepared from the reaction of 1,4-cyclohexane dione (
1
) with elemental sulfur followed by phenyl isothiocyanate
(12)
in absolute ethanol containing triethylamine. The latter compound reacted with ethyl orthoformate and either malononitrile or ethyl cyanoacetate in 1,4-dioxane in the presence of triethylamine to produce the 9-ethoxy-2
H
-chromeno[6,5-
d
]thiazole derivatives
20a,b
. In addition, fused thiophene and pyran derivatives were synthesized starting from compound 18. The screened compounds were designed as mimics of the transition state of RNA2’-
O
-methylation were screened against several viral RNA 2’-
O
MTases from SARS-CoV (nsp10/nsp16 complex), Zika, West Nile, dengue, vaccinia (VP39) viruses. At the same time, the compounds were tested against human RNA N7-MTase (hRNMT) and selected viral N7-MTases such as SARS-CoV nsp14 and vaccinia D1-D12 complex to evaluate their specificity. Compounds
4a
,
4b
,
6b
,
6c
,
6e
,
9a
,
9b
,
15, 16
,
21b
, and
23b
showed high % inhibitions against SARs-Cov nsp 14 with values 93.42, 87.49, 98.23, 88.15, 89.24, 96.31, 93.28, 89.25, 89.20, 87.24, and 94.49, respectively.